The association between compliance and persistence with bisphosphonate therapy and fracture risk: a review (Q33300458)

25 July 2017

6 references

13 March 2019

24 March 2019

12 November 2019

29 October 2020

18 January 2021

30 July 2022

The association between compliance and persistence with bisphosphonate therapy and fracture risk: a review (English)

1 reference

postmenopausal osteoporosis

25 July 2017

6 references

13 March 2019

24 March 2019

12 November 2019

29 October 2020

18 January 2021

30 July 2022

organic compound, having C-P covalent bound

1 reference

12 November 2019

2 references

29 October 2020

30 July 2022

1 reference

18 January 2021

Jonathan Adachi

1

1 reference

25 July 2017

Niall Lynch

2

1 reference

25 July 2017

Hans Middelhoven

3

1 reference

25 July 2017

Manjit Hunjan

4

1 reference

25 July 2017

Warren Cowell

5

1 reference

25 July 2017

language of work or name

1 reference

26 September 2007

7 references

BMC Musculoskeletal Disorders

25 July 2017

13 March 2019

24 March 2019

12 November 2019

29 October 2020

18 January 2021

30 July 2022

7 references

25 July 2017

13 March 2019

24 March 2019

12 November 2019

29 October 2020

18 January 2021

30 July 2022

8

1 reference

25 July 2017

97

1 reference

Creative Commons Attribution 2.0 Generic

25 July 2017

6 references

13 March 2019

24 March 2019

12 November 2019

29 October 2020

18 January 2021

on focus list of Wikimedia project

30 July 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2474-8-97

0 references

cites work

A systematic review of persistence and compliance with bisphosphonates for osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094708

Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094708

Estimating medication persistency using administrative claims data.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094708

Interventions to enhance patient adherence to medication prescriptions: scientific review.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094708

Osteoporosis prevention, diagnosis, and therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094708

Assessing compliance to antihypertensive medications using computer-based pharmacy records.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094708

Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094708

Compliance with treatment regimens in chronic asymptomatic diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094708

Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-97

Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-97

Compliance with pharmacologic therapy for osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-97

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-97

Adherence to bisphosphonates and hormone replacement therapy in a tertiary care setting of patients in the CANDOO database

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-97

Compliance with drug therapies for the treatment and prevention of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-97

Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-97

Compliance of osteoporotic patients with different treatment regimens

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094708

American Association of Clinical Endocrinologists 2001 Medical Guidelines for Clinical Practice for the Prevention and Management of Postmenopausal Osteoporosis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2094708

Assessment of compliance with osteoporosis treatment and its consequences in a managed care population

31 October 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2474-8-97

Long-term persistence in use of statin therapy in elderly patients

21 January 2018

1 reference

12 December 2020

The impact of dosing frequency on compliance and persistence with bisphosphonates among postmenopausal women in the UK: evidence from three databases

1 reference

12 December 2020

Compliance with drug therapy for postmenopausal osteoporosis

1 reference

12 December 2020

The effect of dosing frequency on compliance and persistence with bisphosphonate therapy in postmenopausal women: a comparison of studies in the United States, the United Kingdom, and France

1 reference

12 December 2020

Compliance with osteoporosis drug therapy and risk of fracture

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2474-8-97

1 reference

Dimensions Publication ID

25 July 2017

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2474-8-97

9 September 2019

1 reference

25 July 2017

1 reference